首页 > 最新文献

American Journal of Obstetrics & Gynecology Mfm最新文献

英文 中文
Examining the role of neighborhood-level sociostructural indices in predicting spontaneous preterm birth in the New York City metropolitan area 检查邻里水平的社会结构指数在预测自发性早产在纽约市大都市区的作用。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-08 DOI: 10.1016/j.ajogmf.2025.101837
Daniel L. Kuhr MD , Nicola F. Tavella MPH , Zahava P. Michaelson MD , Raina Kishan MD , Nicole Parkas BS, RDMS , Rebecca M. Cohen BSE , Chelsea A. DeBolt MD, MSCR , Helen Feltovich MD, MS , Kimberly B. Glazer PhD, MPH

Background

Prior predictive models of spontaneous preterm birth that include cervical length and other individual covariates have achieved only moderate discriminative strength. Indices which reflect the sociostructural environment have been associated with preterm birth overall, but the extent to which these measures may improve prediction of spontaneous preterm birth among individuals with measured cervical length has not been tested.

Objectives

To determine whether a cervical length model including measures of the neighborhood-level social environment increases spontaneous preterm birth discrimination compared with a cervical length model without such indices.

Methods

This was a retrospective cohort study of all gestations with (1) delivery between January, 2013 and August, 2023 and (2) at least one transvaginal cervical length measurement between 16 weeks and 0 days’ and 24 weeks and 6 days’ gestation. The primary outcome was spontaneous preterm birth. We ascertained neighborhood-level sociostructural determinants of health from the Index of Concentration at the Extremes (ICE) and Child Opportunity Index (COI). We used logistic regression to predict the probability of spontaneous preterm birth in models with (1) cervical length alone, (2) cervical length plus social indices, and (3) cervical length, social indices, and individual characteristics. We examined model discrimination using the area under the receiver operating characteristics curve (AUC) and 95% confidence intervals. We used the net reclassification index (NRI) to quantify the improvement in predictive ability between nested models.

Results

1884 pregnancies were included, of which 119 (6.3%) resulted in spontaneous preterm birth. A model with cervical length alone achieved an AUC of 0.66 (0.60, 0.72), increasing to 0.75 (0.70, 0.79) with individual covariates. Adding social indices yielded a model with an AUC of 0.75 (0.71, 0.80). The model with cervical length, individual covariates, and social indices had an NRI of 0.04 (0.01, 0.08), indicating improved performance compared with the previous models.

Conclusions

Among individuals with cervical length screening, the inclusion of social indices improved the prediction of spontaneous preterm birth compared to a model with only individual-level covariates.
背景:包括宫颈长度和其他个体协变量在内的自发性早产的先前预测模型仅达到中等判别强度。反映社会结构环境的指数总体上与早产有关,但这些措施在多大程度上可以改善对测量宫颈长度的个体的自发性早产的预测,尚未经过测试。目的:确定与不包含这些指标的宫颈长度模型相比,包含邻里社会环境措施的宫颈长度模型是否会增加自发性早产歧视。方法:本研究为回顾性队列研究,纳入2013年1月至2023年8月期间分娩的所有妊娠,以及妊娠16周至0天和24周至6天期间至少一次经阴道宫颈长度测量的所有妊娠。主要结局为自发性早产。我们从极端浓度指数(ICE)和儿童机会指数(COI)确定了社区水平的健康社会结构决定因素。我们采用logistic回归预测1)宫颈长度单独、2)宫颈长度加社会指数、3)宫颈长度、社会指数和个体特征模型的自发性早产概率。我们使用接收者工作特征曲线(AUC)下的面积和95%置信区间来检验模型判别。我们使用净重分类指数(NRI)来量化嵌套模型之间预测能力的提高。结果:共纳入1884例妊娠,其中自发性早产119例(6.3%)。单独考虑颈椎长度的模型的AUC为0.66(0.60,0.72),随着个体协变量的增加,AUC为0.75(0.70,0.79)。加入社会指数得到AUC为0.75(0.71,0.80)的模型。包含颈椎长度、个体协变量和社会指标的模型的NRI为0.04(0.01,0.08),与之前的模型相比,性能有所提高。结论:在进行宫颈长度筛查的个体中,与仅包含个体水平协变量的模型相比,纳入社会指标可改善自发性早产的预测。
{"title":"Examining the role of neighborhood-level sociostructural indices in predicting spontaneous preterm birth in the New York City metropolitan area","authors":"Daniel L. Kuhr MD ,&nbsp;Nicola F. Tavella MPH ,&nbsp;Zahava P. Michaelson MD ,&nbsp;Raina Kishan MD ,&nbsp;Nicole Parkas BS, RDMS ,&nbsp;Rebecca M. Cohen BSE ,&nbsp;Chelsea A. DeBolt MD, MSCR ,&nbsp;Helen Feltovich MD, MS ,&nbsp;Kimberly B. Glazer PhD, MPH","doi":"10.1016/j.ajogmf.2025.101837","DOIUrl":"10.1016/j.ajogmf.2025.101837","url":null,"abstract":"<div><h3>Background</h3><div>Prior predictive models of spontaneous preterm birth that include cervical length and other individual covariates have achieved only moderate discriminative strength. Indices which reflect the sociostructural environment have been associated with preterm birth overall, but the extent to which these measures may improve prediction of spontaneous preterm birth among individuals with measured cervical length has not been tested.</div></div><div><h3>Objectives</h3><div>To determine whether a cervical length model including measures of the neighborhood-level social environment increases spontaneous preterm birth discrimination compared with a cervical length model without such indices.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study of all gestations with (1) delivery between January, 2013 and August, 2023 and (2) at least one transvaginal cervical length measurement between 16 weeks and 0 days’ and 24 weeks and 6 days’ gestation. The primary outcome was spontaneous preterm birth. We ascertained neighborhood-level sociostructural determinants of health from the Index of Concentration at the Extremes (ICE) and Child Opportunity Index (COI). We used logistic regression to predict the probability of spontaneous preterm birth in models with (1) cervical length alone, (2) cervical length plus social indices, and (3) cervical length, social indices, and individual characteristics. We examined model discrimination using the area under the receiver operating characteristics curve (AUC) and 95% confidence intervals. We used the net reclassification index (NRI) to quantify the improvement in predictive ability between nested models.</div></div><div><h3>Results</h3><div>1884 pregnancies were included, of which 119 (6.3%) resulted in spontaneous preterm birth. A model with cervical length alone achieved an AUC of 0.66 (0.60, 0.72), increasing to 0.75 (0.70, 0.79) with individual covariates. Adding social indices yielded a model with an AUC of 0.75 (0.71, 0.80). The model with cervical length, individual covariates, and social indices had an NRI of 0.04 (0.01, 0.08), indicating improved performance compared with the previous models.</div></div><div><h3>Conclusions</h3><div>Among individuals with cervical length screening, the inclusion of social indices improved the prediction of spontaneous preterm birth compared to a model with only individual-level covariates.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101837"},"PeriodicalIF":3.1,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review of transvaginal ultrasound assessment of cesarean scar characteristics and prediction of adverse obstetric outcomes 经阴道超声评估剖宫产瘢痕特征和预测不良产科结局的系统综述。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-08 DOI: 10.1016/j.ajogmf.2025.101839
Amrita Banerjee MBBS , Roberta Solda MD , Maria Ivan MBBS , Charlotte Colley MBBS , Davor Jurkovic MD , Anna L. David PhD , Raffaele Napolitano MD, PhD
<div><h3>OBJECTIVE</h3><div>This study aimed to investigate the association between preconception and antenatal ultrasound characteristics of cesarean delivery scars and adverse obstetrical outcomes in subsequent pregnancies.</div></div><div><h3>DATA SOURCES</h3><div>Literature searches were performed in MEDLINE, Embase, and Cochrane databases from inception to January 31, 2024.</div></div><div><h3>STUDY ELIGIBILITY CRITERIA</h3><div>Eligible studies included studies that evaluated cesarean delivery scar and niche characteristics using transvaginal ultrasound during preconception and/or antenatally and described subsequent adverse obstetrical outcomes (placenta accreta spectrum, preterm birth, uterine dehiscence/rupture, and unsuccessful vaginal birth after cesarean delivery).</div></div><div><h3>METHODS</h3><div>A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews registration number: CRD 42019121523). Of note, 2 reviewers independently screened records and assessed eligible articles. The quality of publication was assessed using the Cochrane Collaboration tool and Newcastle-Ottawa Scale. The data were summarized using descriptive statistics.</div></div><div><h3>RESULTS</h3><div>In 19 included studies, the definition of niche, large niche, and cesarean delivery scar assessment timing varied widely. Scar visibility was reported to be between 78% and 100% in the first trimester of pregnancy and between 68% and 91% in the second trimester of pregnancy. The prevalence rates of niche detection were 65% to 97% before conception and 52% to 58% during pregnancy. Uterine dehiscence/rupture was the most common adverse outcome reported (13 studies) and was associated with a large niche, a higher niche depth–to–residual myometrial thickness ratio (≥0.785), a thin residual myometrial thickness, and a higher average decrease in residual myometrial thickness between the first and second trimesters of pregnancy. Owing to methodological study heterogeneity and insufficient description of definitions, optimal cutoffs could not be defined. Of note, 3 studies evaluated the screening for placenta accreta spectrum using first-trimester cesarean delivery scar characteristics. An exposed cesarean delivery scar above the cervicoisthmic canal with placental implantation over the scar or within the niche had high sensitivity (75.0%–100.0%) and negative predictive value (99.6%–100.0%) for placenta accreta spectrum. Of note, 1 study found that a low scar after full dilatation cesarean delivery (a scar within the cervix or <5.0 mm above the internal cervical os) was associated with an increased risk of shortening cervical length and/or spontaneous preterm birth (adjusted odds ratio, 12.7 [95% confidence interval, 4.5–36.0]; <em>P≤</em>.0001).</div></div><div><h3>CONCLUSION</h3><div>This systematic review found that cesarean delivery scar chara
目的:探讨剖宫产(CD)疤痕的孕前和/或产前超声特征与随后妊娠的不良产科结局之间的关系。数据来源:文献检索(MEDLINE, Embase, Cochrane数据库)从成立到2024年1月31日。研究资格标准:符合条件的研究在孕前和/或产前通过阴道超声评估CD疤痕和生态位特征,并描述随后的不良产科结局(胎盘增生谱、PAS、早产、PTB、子宫开裂/破裂、CD后阴道分娩失败)。研究评价和综合方法:根据PRISMA指南进行系统评价(PROSPERO注册:CRD 42019121523)。两位审稿人独立筛选记录并评估符合条件的文章。采用Cochrane协作工具和纽卡斯尔-渥太华量表(Newcastle-Ottawa Scale, NOS)评估文章质量。用描述性统计对数据进行汇总。结果:在纳入的19项研究中,生态位、大生态位的定义和CD疤痕评估时间差异很大。据报道,疤痕可见度在妊娠早期和中期分别为78-100%和68-91%。孕前生态位检出率为65 ~ 97%,孕期为52 ~ 58%。子宫开裂/破裂是最常见的不良结果(13项研究),其相关因素包括:大的子宫位、较高的子宫位深度/残余肌层厚度(RMT)比(≥0.785)、较薄的RMT以及妊娠早期和中期RMT的较高平均下降。由于方法学研究的异质性和定义描述的不充分,无法确定最佳截止点。三项研究评估了使用妊娠早期CD疤痕特征筛查PAS。暴露于颈峡管上方的CD瘢痕,在瘢痕上方或生态位内植入胎盘,PAS的敏感性为75-100%,阴性预测值为99.6-100%。一项研究发现充分扩张CD后出现低瘢痕(宫颈内瘢痕)或结论:该系统综述发现CD瘢痕特征与子宫破裂/裂孔、PAS和sPTB等不良产科结局相关。需要使用标准化CD疤痕评估的多中心前瞻性研究来建立最佳管理和妊娠咨询的预测数据。
{"title":"A systematic review of transvaginal ultrasound assessment of cesarean scar characteristics and prediction of adverse obstetric outcomes","authors":"Amrita Banerjee MBBS ,&nbsp;Roberta Solda MD ,&nbsp;Maria Ivan MBBS ,&nbsp;Charlotte Colley MBBS ,&nbsp;Davor Jurkovic MD ,&nbsp;Anna L. David PhD ,&nbsp;Raffaele Napolitano MD, PhD","doi":"10.1016/j.ajogmf.2025.101839","DOIUrl":"10.1016/j.ajogmf.2025.101839","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;OBJECTIVE&lt;/h3&gt;&lt;div&gt;This study aimed to investigate the association between preconception and antenatal ultrasound characteristics of cesarean delivery scars and adverse obstetrical outcomes in subsequent pregnancies.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;DATA SOURCES&lt;/h3&gt;&lt;div&gt;Literature searches were performed in MEDLINE, Embase, and Cochrane databases from inception to January 31, 2024.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;STUDY ELIGIBILITY CRITERIA&lt;/h3&gt;&lt;div&gt;Eligible studies included studies that evaluated cesarean delivery scar and niche characteristics using transvaginal ultrasound during preconception and/or antenatally and described subsequent adverse obstetrical outcomes (placenta accreta spectrum, preterm birth, uterine dehiscence/rupture, and unsuccessful vaginal birth after cesarean delivery).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;METHODS&lt;/h3&gt;&lt;div&gt;A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews registration number: CRD 42019121523). Of note, 2 reviewers independently screened records and assessed eligible articles. The quality of publication was assessed using the Cochrane Collaboration tool and Newcastle-Ottawa Scale. The data were summarized using descriptive statistics.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;RESULTS&lt;/h3&gt;&lt;div&gt;In 19 included studies, the definition of niche, large niche, and cesarean delivery scar assessment timing varied widely. Scar visibility was reported to be between 78% and 100% in the first trimester of pregnancy and between 68% and 91% in the second trimester of pregnancy. The prevalence rates of niche detection were 65% to 97% before conception and 52% to 58% during pregnancy. Uterine dehiscence/rupture was the most common adverse outcome reported (13 studies) and was associated with a large niche, a higher niche depth–to–residual myometrial thickness ratio (≥0.785), a thin residual myometrial thickness, and a higher average decrease in residual myometrial thickness between the first and second trimesters of pregnancy. Owing to methodological study heterogeneity and insufficient description of definitions, optimal cutoffs could not be defined. Of note, 3 studies evaluated the screening for placenta accreta spectrum using first-trimester cesarean delivery scar characteristics. An exposed cesarean delivery scar above the cervicoisthmic canal with placental implantation over the scar or within the niche had high sensitivity (75.0%–100.0%) and negative predictive value (99.6%–100.0%) for placenta accreta spectrum. Of note, 1 study found that a low scar after full dilatation cesarean delivery (a scar within the cervix or &lt;5.0 mm above the internal cervical os) was associated with an increased risk of shortening cervical length and/or spontaneous preterm birth (adjusted odds ratio, 12.7 [95% confidence interval, 4.5–36.0]; &lt;em&gt;P≤&lt;/em&gt;.0001).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;CONCLUSION&lt;/h3&gt;&lt;div&gt;This systematic review found that cesarean delivery scar chara","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101839"},"PeriodicalIF":3.1,"publicationDate":"2025-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical activity during pregnancy and depression, anxiety and stress: randomized clinical trials 怀孕期间的体育锻炼与抑郁、焦虑和压力:随机临床试验。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-07 DOI: 10.1016/j.ajogmf.2025.101835
Miguel Sánchez-Polán PhD , Maia Brik MD, PhD , Cristina Silva-Jose PhD , Dingfeng Zhang PhD , María Ángeles Díaz-Blanco , Paloma Hernando López de la Manzanara MD , Aránzazu Martín Arias MD , Irune Alzola MD , Rubén Barakat PhD

Background

Pregnancy is not an emotionally stable period; pregnant women could suffer psychological lability influenced by hormonal variation between trimesters of gestation. The COVID-19 pandemic and the lack of social interaction increased this psychological instability, increasing the reported rates of prevalence of depression and anxiety, with its associated maternal and fetal complications. Despite the fact that regular physical activity could help regulate hormonal secretion, during the pandemic, its performance decreased, increasing sedentary rates. Pharmacological treatment could imply potential health risks, so a non-invasive intervention is needed.

Objective

To assess the impact of two supervised physical activity programs during pregnancy on prenatal and postnatal depression, anxiety and stress symptoms.

Study design

Two randomized clinical trials were developed, with physical activity programs during pregnancy being carried out, randomizing 564 pregnant women in both the Intervention (n=278) and the Control (n=278) groups, of three different regions (and five health centers) from Spain. Three weekly physical activity sessions, online and in-person were performed until the end of pregnancy, measuring depression (measured with CES-D and EPDS), anxiety (STAI) and stress (PSS) symptoms. SPSS software was used, and independent t tests, U Mann Whitney, Pearson Chi-square and one-way ANOVA analyses were used.

Results

After intervention, results showed a significant reduction in depression symptoms in the Per Protocol (P=.028) analysis, with also fewer cases of symptoms compatible with depression at the end of gestation, in the Intention to Treat (5.9% / 12.4%) and Per Protocol (3.2% / 12.2%) analyses in the intervention group, in comparison with the control group. Additionally, significantly lower scores were found in pregnant women with more than 90% of program attendance in depression (P=.003) and in state anxiety (P=.035) at the end of pregnancy compared with women that not accomplished protocol criteria (<70% attendance). Analysis per trial, revealed significant lower scores in depression (P=.043), state (P=.015), trait (P=.045) anxiety and in the combination of both (P=.021), in IG of the 2nd trial, compared with CG. No significant differences were observed in scores of depression, anxiety or stress during and after pregnancy in the Intention to Treat analysis (P>.05).

Conclusion

Supervised physical activity during pregnancy could potentially reduce prenatal depression symptoms at the end of gestation and, comparatively, enhance the effects by greater reducing state anxiety and depression symptoms when adherence is greater than 90%.
背景:孕期不是一个情绪稳定的时期;在怀孕的三个月期间,由于荷尔蒙的变化,孕妇可能会遭受心理不稳定的影响。COVID-19大流行和缺乏社会互动加剧了这种心理不稳定,增加了报告的抑郁和焦虑患病率,并伴有相关的孕产妇和胎儿并发症。尽管有规律的体育活动可以帮助调节激素分泌,但在大流行期间,其性能下降,久坐率增加。药物治疗可能意味着潜在的健康风险,因此需要非侵入性干预。目的:评价两种孕期监督体育锻炼方案对产前和产后抑郁、焦虑和应激症状的影响。研究设计:开发了两项随机临床试验,在怀孕期间进行体育锻炼计划,随机抽取564名孕妇,分别来自西班牙三个不同地区(和五个健康中心)的干预组(n = 278)和对照组(n = 278)。在怀孕结束前,每周进行三次在线和面对面的身体活动,测量抑郁(用CES-D和EPDS测量)、焦虑(STAI)和压力(PSS)症状。采用SPSS软件,采用独立t检验、U Mann Whitney、Pearson Chi-square和单因素方差分析。结果:干预后,结果显示,与对照组相比,干预组在Per方案(p = .028)分析中抑郁症状显著减少,在治疗意向(5.9% / 12.4%)和Per方案(3.2% / 12.2%)分析中妊娠末期与抑郁症状相一致的病例也较少。此外,与未完成方案标准(和试验,与CG相比)的妇女相比,在怀孕结束时,超过90%的参加计划的孕妇在抑郁(p = .003)和状态焦虑(p = .035)方面的得分明显较低。在意向治疗分析中,在怀孕期间和怀孕后的抑郁、焦虑或压力得分上没有观察到显著差异(p < 0.05)。结论:孕期有监督的体力活动可以潜在地减少妊娠末期的产前抑郁症状,相对而言,当依从性大于90%时,更能减少状态焦虑和抑郁症状,从而增强效果。
{"title":"Physical activity during pregnancy and depression, anxiety and stress: randomized clinical trials","authors":"Miguel Sánchez-Polán PhD ,&nbsp;Maia Brik MD, PhD ,&nbsp;Cristina Silva-Jose PhD ,&nbsp;Dingfeng Zhang PhD ,&nbsp;María Ángeles Díaz-Blanco ,&nbsp;Paloma Hernando López de la Manzanara MD ,&nbsp;Aránzazu Martín Arias MD ,&nbsp;Irune Alzola MD ,&nbsp;Rubén Barakat PhD","doi":"10.1016/j.ajogmf.2025.101835","DOIUrl":"10.1016/j.ajogmf.2025.101835","url":null,"abstract":"<div><h3>Background</h3><div>Pregnancy is not an emotionally stable period; pregnant women could suffer psychological lability influenced by hormonal variation between trimesters of gestation. The COVID-19 pandemic and the lack of social interaction increased this psychological instability, increasing the reported rates of prevalence of depression and anxiety, with its associated maternal and fetal complications. Despite the fact that regular physical activity could help regulate hormonal secretion, during the pandemic, its performance decreased, increasing sedentary rates. Pharmacological treatment could imply potential health risks, so a non-invasive intervention is needed.</div></div><div><h3>Objective</h3><div>To assess the impact of two supervised physical activity programs during pregnancy on prenatal and postnatal depression, anxiety and stress symptoms.</div></div><div><h3>Study design</h3><div>Two randomized clinical trials were developed, with physical activity programs during pregnancy being carried out, randomizing 564 pregnant women in both the Intervention (n=278) and the Control (n=278) groups, of three different regions (and five health centers) from Spain. Three weekly physical activity sessions, online and in-person were performed until the end of pregnancy, measuring depression (measured with CES-D and EPDS), anxiety (STAI) and stress (PSS) symptoms. SPSS software was used, and independent t tests, U Mann Whitney, Pearson Chi-square and one-way ANOVA analyses were used.</div></div><div><h3>Results</h3><div>After intervention, results showed a significant reduction in depression symptoms in the Per Protocol (<em>P=.</em>028) analysis, with also fewer cases of symptoms compatible with depression at the end of gestation, in the Intention to Treat (5.9% / 12.4%) and Per Protocol (3.2% / 12.2%) analyses in the intervention group, in comparison with the control group. Additionally, significantly lower scores were found in pregnant women with more than 90% of program attendance in depression (<em>P=.</em>003) and in state anxiety (<em>P=.</em>035) at the end of pregnancy compared with women that not accomplished protocol criteria (&lt;70% attendance). Analysis per trial, revealed significant lower scores in depression (<em>P=.</em>043), state (<em>P=.</em>015), trait (<em>P=.</em>045) anxiety and in the combination of both (<em>P=.</em>021), in IG of the 2<sup>nd</sup> trial, compared with CG. No significant differences were observed in scores of depression, anxiety or stress during and after pregnancy in the Intention to Treat analysis (<em>P&gt;.</em>05).</div></div><div><h3>Conclusion</h3><div>Supervised physical activity during pregnancy could potentially reduce prenatal depression symptoms at the end of gestation and, comparatively, enhance the effects by greater reducing state anxiety and depression symptoms when adherence is greater than 90%.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101835"},"PeriodicalIF":3.1,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy 妊娠期高血压疾病患者的产后保健利用与降压药的血压控制
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-07 DOI: 10.1016/j.ajogmf.2025.101836
Carrie Bennett MD , Lara Lemon PharmD, PhD , Kripa Venkatakrishnan MPH , Sanjana Ghosh BS , Hyagriv Simhan MD, MS , Alisse Hauspurg MD, MS
<div><h3>BACKGROUND</h3><div>Hypertensive disorders of pregnancy are a significant contributor to maternal morbidity and mortality in the postpartum period and are the leading cause of postpartum readmission following delivery hospitalization. At present, there remains uncertainty regarding differences in postpartum health care utilization for individuals discharged on specific antihypertensive agents while enrolled in an institutional remote blood pressure (BP) monitoring program.</div></div><div><h3>OBJECTIVE</h3><div>To evaluate rates of postpartum hospital readmission and emergency room (ER) utilization for individuals with a hypertensive disorder of pregnancy (HDP) enrolled in remote BP monitoring after discharge on labetalol vs nifedipine.</div></div><div><h3>STUDY DESIGN</h3><div>We performed a retrospective cohort study to evaluate outcomes associated with the type of antihypertensive medication at discharge in postpartum individuals delivering between April 2019 and June 2023 at a single institution. The exposure of interest was discharge on single-agent labetalol vs nifedipine. Individuals were included who were diagnosed with hypertension (HTN) in pregnancy (including pre-pregnancy HTN) and were enrolled in our institution’s remote BP management program. Our institution’s remote program monitors BP up to 6 months postpartum. Individuals were excluded if they were prescribed antihypertensives antenatally. We compared demographics, clinical outcomes, and home BP measures between groups. The primary outcome was postpartum hospital readmission and ER visits within 8 weeks of delivery. Multivariate logistic regression models adjusted for severity of HDP, TIS, race, and BMI.</div></div><div><h3>RESULTS</h3><div>1507 individuals were included; 488 (32.4%) were discharged on labetalol and 1019 (67.6%) on nifedipine. Those discharged on labetalol had higher BMIs and higher rates of pre-pregnancy HTN. Compared to individuals discharged on labetalol, those discharged on nifedipine were less likely to have a postpartum hospital readmission (9.2% vs 3.9%, <em>P<.</em>001). In multivariate logistic regression models, discharge on labetalol was associated with a significant increased odds of postpartum hospital readmission [aOR 2.70 (95% CI 1.57–4.65)] but not ED visits [aOR 1.01 (95% CI 0.67–1.52)] compared with discharge on nifedipine. These findings were similar with stratification by pre-pregnancy HTN. Upon analysis of home postpartum BP data, we found that the proportion of blood pressures in the severe range by each postpartum day was higher in the first ten days postpartum for those discharged on labetalol as compared to nifedipine.</div></div><div><h3>CONCLUSION</h3><div>Discharge on labetalol was associated with an increased odds of postpartum hospital readmission following a HDP compared with discharge on nifedipine. Our findings suggest this may be driven by more severe hypertension on home monitoring by each day postpartum in the first
背景:妊娠期高血压疾病是导致产妇产后发病率和死亡率的重要因素,也是产后住院后再入院的主要原因。目前,在接受机构远程血压监测项目的个体中,使用特定降压药出院的个体在产后保健利用方面的差异仍然存在不确定性。目的:评价远程血压监测妊娠期高血压疾病(HDP)患者出院后使用拉贝他洛尔与硝苯地平的再入院率和急诊室(ER)使用率。研究设计:我们进行了一项回顾性队列研究,以评估2019年4月至2023年6月在单一机构分娩的产后个体出院时抗高血压药物类型的相关结果。感兴趣的暴露是单药拉比他洛尔与硝苯地平的对比。被诊断为妊娠期高血压(HTN)(包括孕前HTN)的个体被纳入我们机构的远程血压管理项目。我们机构的远程程序监测产后6个月的血压。如果个人在产前服用了抗高血压药,则被排除在外。我们比较了两组之间的人口统计学、临床结果和家庭血压测量。主要结局是产后住院再入院和分娩8周内急诊就诊。多变量logistic回归模型调整了HDP、TIS、种族和BMI的严重程度。结果:共纳入1507人;使用拉贝他洛尔出院488例(32.4%),使用硝苯地平出院1019例(67.6%)。使用拉贝他洛尔出院的患者有较高的bmi和较高的孕前HTN率。与使用拉贝他洛尔出院的患者相比,使用硝苯地平出院的患者产后再入院的可能性更低(9.2% vs 3.9%)。结论:与使用硝苯地平出院的患者相比,使用拉贝他洛尔出院的患者产后再入院的几率增加。我们的研究结果表明,这可能是由于产后10天每天在家监测更严重的高血压所致。
{"title":"Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy","authors":"Carrie Bennett MD ,&nbsp;Lara Lemon PharmD, PhD ,&nbsp;Kripa Venkatakrishnan MPH ,&nbsp;Sanjana Ghosh BS ,&nbsp;Hyagriv Simhan MD, MS ,&nbsp;Alisse Hauspurg MD, MS","doi":"10.1016/j.ajogmf.2025.101836","DOIUrl":"10.1016/j.ajogmf.2025.101836","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;BACKGROUND&lt;/h3&gt;&lt;div&gt;Hypertensive disorders of pregnancy are a significant contributor to maternal morbidity and mortality in the postpartum period and are the leading cause of postpartum readmission following delivery hospitalization. At present, there remains uncertainty regarding differences in postpartum health care utilization for individuals discharged on specific antihypertensive agents while enrolled in an institutional remote blood pressure (BP) monitoring program.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;OBJECTIVE&lt;/h3&gt;&lt;div&gt;To evaluate rates of postpartum hospital readmission and emergency room (ER) utilization for individuals with a hypertensive disorder of pregnancy (HDP) enrolled in remote BP monitoring after discharge on labetalol vs nifedipine.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;STUDY DESIGN&lt;/h3&gt;&lt;div&gt;We performed a retrospective cohort study to evaluate outcomes associated with the type of antihypertensive medication at discharge in postpartum individuals delivering between April 2019 and June 2023 at a single institution. The exposure of interest was discharge on single-agent labetalol vs nifedipine. Individuals were included who were diagnosed with hypertension (HTN) in pregnancy (including pre-pregnancy HTN) and were enrolled in our institution’s remote BP management program. Our institution’s remote program monitors BP up to 6 months postpartum. Individuals were excluded if they were prescribed antihypertensives antenatally. We compared demographics, clinical outcomes, and home BP measures between groups. The primary outcome was postpartum hospital readmission and ER visits within 8 weeks of delivery. Multivariate logistic regression models adjusted for severity of HDP, TIS, race, and BMI.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;RESULTS&lt;/h3&gt;&lt;div&gt;1507 individuals were included; 488 (32.4%) were discharged on labetalol and 1019 (67.6%) on nifedipine. Those discharged on labetalol had higher BMIs and higher rates of pre-pregnancy HTN. Compared to individuals discharged on labetalol, those discharged on nifedipine were less likely to have a postpartum hospital readmission (9.2% vs 3.9%, &lt;em&gt;P&lt;.&lt;/em&gt;001). In multivariate logistic regression models, discharge on labetalol was associated with a significant increased odds of postpartum hospital readmission [aOR 2.70 (95% CI 1.57–4.65)] but not ED visits [aOR 1.01 (95% CI 0.67–1.52)] compared with discharge on nifedipine. These findings were similar with stratification by pre-pregnancy HTN. Upon analysis of home postpartum BP data, we found that the proportion of blood pressures in the severe range by each postpartum day was higher in the first ten days postpartum for those discharged on labetalol as compared to nifedipine.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;CONCLUSION&lt;/h3&gt;&lt;div&gt;Discharge on labetalol was associated with an increased odds of postpartum hospital readmission following a HDP compared with discharge on nifedipine. Our findings suggest this may be driven by more severe hypertension on home monitoring by each day postpartum in the first","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101836"},"PeriodicalIF":3.1,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145482841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective fetal growth restriction type II: IIb or not IIb 选择性胎儿生长限制(sFGR) II型:IIb或非IIb。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-06 DOI: 10.1016/j.ajogmf.2025.101833
Ariane C. Youssefzadeh MD, Ramen H. Chmait MD
Monochorionic diamniotic twins have distinct risk profiles because of their single shared placenta. Selective fetal growth restriction complicates monochorionic diamniotic twin pregnancies by up to 25% because of unequal placental share, vascular anastomoses (aberrant sizes, quantities, and types), and discrepant cord insertion sites. Since 2007, the Gratacos classification system has been used to better understand the risk of selective fetal growth restriction based on the umbilical artery Doppler findings of the selective fetal growth restriction fetus, where type I has forward diastolic flow, type II has persistent absent or reversed end-diastolic flow, and type III has intermittent absent or reversed end-diastolic flow. Type I has an excellent prognosis, and type III is characterized by its unpredictable clinical course. This review focuses on early selective fetal growth restriction type II, which is generally considered to predict the worst outcome, with high rates of perinatal morbidity and mortality. Despite selective fetal growth restriction being relatively common, the optimal management remains controversial. Management strategies include expectant management, cord occlusion of the smaller twin to protect the appropriate grown twin, and selective laser photocoagulation of communicating vessels to unlink the fates of the twins. The clinical course of selective fetal growth restriction type II is not uniform, and a nuanced approach plays a role. Our study describes the management dilemma associated with early selective fetal growth restriction type II overall and the justification for the subclassification into type IIa vs type IIb, which may help stratify patients’ prognoses and management plans.
单绒毛膜双胎(MCDA)双胞胎有不同的风险概况,由于他们的单一共享胎盘。选择性胎儿生长限制(sFGR)导致高达25%的MCDA并发症,原因是胎盘份额不均等、血管吻合(大小、数量和类型异常)和脐带插入位置不一致。自2007年以来,Gratacos分类系统被用于更好地了解sFGR胎儿的风险,基于脐动脉多普勒检查结果,其中I型为前向舒张血流,II型为持续的舒张末期血流缺失或逆转,III型为间歇性的舒张末期血流缺失或逆转。I型通常预后良好,而III型的特点是其临床病程不可预测。本综述的重点是早期sFGR II型,它通常被认为是预测最坏的结果,具有高围产期发病率和死亡率。尽管sFGR相对常见,但最佳管理仍存在争议。治疗策略包括期待治疗,小双胞胎脐带闭塞以保护适当的成年双胞胎,以及选择性激光光凝交通血管(SLPCV)以解除双胞胎的命运。sFGR II型的临床病程并不统一,需要采用细致入微的方法。在本文中,我们描述了与早期sFGR II型相关的管理困境,以及将其分为IIa型和IIb型的理由,这可能有助于对患者的预后和管理计划进行分层。
{"title":"Selective fetal growth restriction type II: IIb or not IIb","authors":"Ariane C. Youssefzadeh MD,&nbsp;Ramen H. Chmait MD","doi":"10.1016/j.ajogmf.2025.101833","DOIUrl":"10.1016/j.ajogmf.2025.101833","url":null,"abstract":"<div><div>Monochorionic diamniotic twins have distinct risk profiles because of their single shared placenta. Selective fetal growth restriction complicates monochorionic diamniotic twin pregnancies by up to 25% because of unequal placental share, vascular anastomoses (aberrant sizes, quantities, and types), and discrepant cord insertion sites. Since 2007, the Gratacos classification system has been used to better understand the risk of selective fetal growth restriction based on the umbilical artery Doppler findings of the selective fetal growth restriction fetus, where type I has forward diastolic flow, type II has persistent absent or reversed end-diastolic flow, and type III has intermittent absent or reversed end-diastolic flow. Type I has an excellent prognosis, and type III is characterized by its unpredictable clinical course. This review focuses on early selective fetal growth restriction type II, which is generally considered to predict the worst outcome, with high rates of perinatal morbidity and mortality. Despite selective fetal growth restriction being relatively common, the optimal management remains controversial. Management strategies include expectant management, cord occlusion of the smaller twin to protect the appropriate grown twin, and selective laser photocoagulation of communicating vessels to unlink the fates of the twins. The clinical course of selective fetal growth restriction type II is not uniform, and a nuanced approach plays a role. Our study describes the management dilemma associated with early selective fetal growth restriction type II overall and the justification for the subclassification into type IIa vs type IIb, which may help stratify patients’ prognoses and management plans.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101833"},"PeriodicalIF":3.1,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145477136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early pregnancy depressive symptoms and severe maternal morbidity 妊娠早期抑郁症状和孕产妇严重发病率。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.ajogmf.2025.101830
T. Caroline Bank MD , Janet Catov PhD , Jiqiang Wu MSc , Lynn M. Yee MD, MPH , Michelle L. Miller PhD , Rebecca McNeil PhD , Lara S. Lemon PhD, PharmD , Uma M. Reddy MD , Robert M. Silver MD , Kelly Zafman MD , George Saade MD , Judith Chung MD , Courtney D. Lynch PhD , William A. Grobman MD, MBA , Kartik K. Venkatesh MD, PhD

Background

Maternal mental health conditions are common in pregnancy; suboptimal maternal mental health is associated with numerous adverse pregnancy outcomes, including preterm birth, hypertensive disorders of pregnancy, and maternal mortality.

Objective

The relationship between maternal mental health during early pregnancy and subsequent severe maternal morbidity (SMM) remains to be investigated. We examined whether depressive symptoms in early pregnancy were associated with SMM at delivery hospitalization.

Study Design

This was a secondary analysis of data from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be study. In this prospective cohort, nulliparous individuals were followed from the first trimester through delivery at eight centers in the United States. The Edinburgh Postnatal Depression Scales (EPDS) was administered at 6-13 weeks’ gestation and assessed categorically at thresholds (≥10 and ≥13) that are commonly used in clinical practice. The primary outcome was SMM at delivery hospitalization, and secondarily, SMM without transfusion. Relative risk regression using a modified Poisson model with robust error variance was used and adjusted for baseline age, insurance status, tobacco use, and residential Area Deprivation Index. In secondary analyses, we further adjusted for preexisting psychiatric diagnosis and psychotropic medication exposure in early pregnancy.

Results

Among 8,784 nulliparas enrolled in early pregnancy (median gestational age: 12.0 weeks; interquartile range [IQR] 11.0, 13.0), 17.2% and 7.1% of individuals had an EPDS score ≥10 and ≥13, respectively. 2.3% experienced SMM and 0.5% experienced non-transfusion SMM. Having an EPDS ≥10 was associated with a greater frequency of SMM in comparison to having an EPDS <10 (3.0% vs 2.1%; relative risk [RR] 1.42; 95% confidence interval [CI] 1.02, 1.96). However, the relative risk was not significant after adjustment (adjusted relative risk [aRR] 1.17; 95% CI: 0.77, 1.77). Individuals who met the higher EPDS threshold of ≥13 had an increased risk of SMM without transfusion in unadjusted (1.1% vs 0.4%, RR 2.53, 95% CI: 1.13, 5.67) and adjusted analyses (1.1% vs 0.4%, aRR: 3.12; 95% CI: 1.11, 8.81). The above associations were similar after further adjustment for a psychiatric diagnosis and psychotropic medication exposure in early pregnancy.

Conclusion

In a prospective US cohort of nulliparous individuals, severe early pregnancy depressive symptoms were associated with an increased risk of SMM without transfusion. Further data about whether intervention for depression in early pregnancy can affect SMM are needed.
背景:产妇心理健康状况在怀孕期间很常见;产妇心理健康欠佳与许多不良妊娠结局有关,包括早产、妊娠高血压疾病和孕产妇死亡率。目的:探讨妊娠早期孕产妇心理健康状况与随后严重孕产妇发病(SMM)的关系。我们研究了妊娠早期的抑郁症状是否与分娩住院时的SMM有关。研究设计:这是对“未产妊娠结局研究:监测准妈妈”研究数据的二次分析。在这一前瞻性队列研究中,在美国的八个中心对未产个体进行了从妊娠早期到分娩的随访。在妊娠6-13周时使用爱丁堡产后抑郁量表(EPDS),并根据临床实践中常用的阈值(≥10和≥13)进行分类评估。主要结果是分娩住院时的SMM,其次是不输血的SMM。采用修正泊松模型进行相对风险回归,并对基线年龄、保险状况、烟草使用和居住面积剥夺指数进行校正。在二次分析中,我们进一步调整了先前存在的精神病诊断和妊娠早期精神药物暴露。结果:在8784名早期妊娠(中位胎龄:12.0周;四分位间距[IQR] 11.0, 13.0)的孕妇中,分别有17.2%和7.1%的个体EPDS评分≥10和≥13。2.3%经历了SMM, 0.5%经历了非输血SMM。与EPDS≥10的孕妇相比,EPDS≥10的孕妇发生SMM的频率更高。结论:在美国一项未生育个体的前瞻性队列研究中,严重的妊娠早期抑郁症状与不输血的SMM风险增加相关。关于妊娠早期抑郁症干预是否会影响SMM,还需要进一步的数据。
{"title":"Early pregnancy depressive symptoms and severe maternal morbidity","authors":"T. Caroline Bank MD ,&nbsp;Janet Catov PhD ,&nbsp;Jiqiang Wu MSc ,&nbsp;Lynn M. Yee MD, MPH ,&nbsp;Michelle L. Miller PhD ,&nbsp;Rebecca McNeil PhD ,&nbsp;Lara S. Lemon PhD, PharmD ,&nbsp;Uma M. Reddy MD ,&nbsp;Robert M. Silver MD ,&nbsp;Kelly Zafman MD ,&nbsp;George Saade MD ,&nbsp;Judith Chung MD ,&nbsp;Courtney D. Lynch PhD ,&nbsp;William A. Grobman MD, MBA ,&nbsp;Kartik K. Venkatesh MD, PhD","doi":"10.1016/j.ajogmf.2025.101830","DOIUrl":"10.1016/j.ajogmf.2025.101830","url":null,"abstract":"<div><h3>Background</h3><div>Maternal mental health conditions are common in pregnancy; suboptimal maternal mental health is associated with numerous adverse pregnancy outcomes, including preterm birth, hypertensive disorders of pregnancy, and maternal mortality.</div></div><div><h3>Objective</h3><div>The relationship between maternal mental health during early pregnancy and subsequent severe maternal morbidity (SMM) remains to be investigated. We examined whether depressive symptoms in early pregnancy were associated with SMM at delivery hospitalization.</div></div><div><h3>Study Design</h3><div>This was a secondary analysis of data from the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-To-Be study. In this prospective cohort, nulliparous individuals were followed from the first trimester through delivery at eight centers in the United States. The Edinburgh Postnatal Depression Scales (EPDS) was administered at 6-13 weeks’ gestation and assessed categorically at thresholds (≥10 and ≥13) that are commonly used in clinical practice. The primary outcome was SMM at delivery hospitalization, and secondarily, SMM without transfusion. Relative risk regression using a modified Poisson model with robust error variance was used and adjusted for baseline age, insurance status, tobacco use, and residential Area Deprivation Index. In secondary analyses, we further adjusted for preexisting psychiatric diagnosis and psychotropic medication exposure in early pregnancy.</div></div><div><h3>Results</h3><div>Among 8,784 nulliparas enrolled in early pregnancy (median gestational age: 12.0 weeks; interquartile range [IQR] 11.0, 13.0), 17.2% and 7.1% of individuals had an EPDS score ≥10 and ≥13, respectively. 2.3% experienced SMM and 0.5% experienced non-transfusion SMM. Having an EPDS ≥10 was associated with a greater frequency of SMM in comparison to having an EPDS &lt;10 (3.0% vs 2.1%; relative risk [RR] 1.42; 95% confidence interval [CI] 1.02, 1.96). However, the relative risk was not significant after adjustment (adjusted relative risk [aRR] 1.17; 95% CI: 0.77, 1.77). Individuals who met the higher EPDS threshold of ≥13 had an increased risk of SMM without transfusion in unadjusted (1.1% vs 0.4%, RR 2.53, 95% CI: 1.13, 5.67) and adjusted analyses (1.1% vs 0.4%, aRR: 3.12; 95% CI: 1.11, 8.81). The above associations were similar after further adjustment for a psychiatric diagnosis and psychotropic medication exposure in early pregnancy.</div></div><div><h3>Conclusion</h3><div>In a prospective US cohort of nulliparous individuals, severe early pregnancy depressive symptoms were associated with an increased risk of SMM without transfusion. Further data about whether intervention for depression in early pregnancy can affect SMM are needed.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101830"},"PeriodicalIF":3.1,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Care utilization and clinical outcomes among high-risk patients enrolled in a postpartum navigation program: a retrospective matched cohort study 参加产后导航项目的高危患者的护理利用和临床结果:一项回顾性匹配队列研究。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.ajogmf.2025.101829
Alyssa M. Hernandez, Mackenzie O’Connell, Natasha Griffin, Abbey Kruper, Kristine Graettinger, Anna Palatnik, Jacqueline Peebles
<div><h3>Background</h3><div>The postpartum period represents the highest risk time for maternal morbidity and mortality. Patient navigation is a promising intervention to improve maternal outcomes during this high-risk period.</div></div><div><h3>Objective</h3><div>To compare care utilization and clinical outcomes pre- and post-implementation of a postpartum navigation program in a retrospective, matched cohort analysis.</div></div><div><h3>Study Design</h3><div>Pregnant patients >32 weeks’ gestation at risk for postpartum morbidity were invited to participate in a postpartum navigation program between October 2023 and September 2024. Qualifying criteria included intrapartum complications, hypertensive disorders of pregnancy, diabetes, and/or risk factors for perinatal mood and anxiety disorders. The navigator conducted regular check-ins with enrolled patients at delivery, 2, 6, and 12 weeks postpartum to assess physical recovery and psychological health. A matched cohort was created with similarly high-risk patients who delivered in the 18 months before program implementation and received standard care. Subjects were matched 1:1 according to race, ethnicity, parity, delivery method, and high-risk criteria. We compared adherence to standard postpartum care recommendations and clinical outcomes between the matched groups. Program feasibility and acceptability were assessed using retention and patient satisfaction as endpoints.</div></div><div><h3>Results</h3><div>Of the 365 patients who met the eligibility criteria, 167 agreed to participate. Five patients withdrew from the program prior to starting any program activities, and one did not have outcome data available. The 161 patients who remained enrolled were matched to historical controls, totaling a final sample size of 322 patients. All demographic and clinical characteristics were similar between the two groups except for gestational age at delivery, which was earlier in the control group (38.7 weeks, IQR 37.4–39.3) than the intervention group (39.0, IQR 37.7–39.6, <em>P=.</em>047). Total attendance at a comprehensive postpartum visit within 12 weeks of birth did not differ (93.8% vs. 90.1%, <em>P=.</em>22). After adjusting for gestational age at delivery, the intervention group was more likely to complete postpartum depression screening (AOR 1.65, 95% CI 1.02–2.67) and continue breastfeeding at 6 weeks postpartum (AOR 2.17, 95% CI 1.46–5.01). The intervention group had higher rates of enrollment in a remote hypertension monitoring program (98.5% vs. 89.1%, <em>P=.</em>027), which recommends once-daily blood pressure (BP) monitoring for two weeks postpartum. Intervention participants also recorded a higher total number of BP measurements using the monitoring program (12 BPs [IQR 0–26] vs. 0 [IQR 0–2], <em>P<.</em>001). However, enrollment in remote monitoring did not remain statistically significant in the multivariate model. Regarding intervention retention, 80.7% of participants atte
背景:产后是产妇发病率和死亡率最高的危险期。患者导航是一个有希望的干预,以改善产妇的结局在这一高危时期。目的:通过回顾性匹配队列分析,比较产后导航计划实施前后的护理利用情况和临床结果。研究设计:在2023年10月至2024年9月期间,邀请妊娠bb0 ~ 32周有产后发病风险的孕妇参加产后导航项目。合格标准包括产时并发症、妊娠高血压疾病、糖尿病和/或围产期情绪和焦虑障碍的危险因素。导航员在分娩、产后2周、6周和12周对入选患者进行定期检查,以评估身体恢复和心理健康状况。在项目实施前18个月分娩并接受标准治疗的相似高风险患者创建了一个匹配的队列。受试者按种族、民族、胎次、分娩方式和高危标准1:1匹配。我们比较了匹配组对标准产后护理建议的依从性和临床结果。以保留率和患者满意度为终点,评估方案的可行性和可接受性。结果:在符合资格标准的365例患者中,167例同意参与。5名患者在开始任何项目活动之前退出了项目,1名患者没有可用的结果数据。继续登记的161名患者与历史对照组相匹配,最终样本量为322名患者。两组的人口统计学和临床特征均相似,但对照组的分娩胎龄(38.7周,IQR为37.4-39.3)早于干预组(39.0周,IQR为37.7-39.6,p=0.047)。出生12周内全面产后随访的总出席率没有差异(93.8%比90.1%,p=0.22)。调整分娩胎龄后,干预组更有可能完成产后抑郁筛查(AOR 1.65, 95% CI 1.02-2.67),并在产后6周继续母乳喂养(AOR 2.17, 95% CI 1.46-5.01)。干预组参加远程高血压监测项目的比例更高(98.5% vs 89.1%, p=0.027),该项目建议产后两周每天监测一次血压。干预参与者使用监测程序也记录了更高的血压测量总数(12 BP [IQR 0-26] vs. 0 [IQR 0-2])。结论:虽然在实施产后导航程序之前和之后参加全面产后访问的人数相似,但导航与产后护理的关键组成部分的改善有关,即高血压监测,母乳喂养持续时间和心理健康筛查。
{"title":"Care utilization and clinical outcomes among high-risk patients enrolled in a postpartum navigation program: a retrospective matched cohort study","authors":"Alyssa M. Hernandez,&nbsp;Mackenzie O’Connell,&nbsp;Natasha Griffin,&nbsp;Abbey Kruper,&nbsp;Kristine Graettinger,&nbsp;Anna Palatnik,&nbsp;Jacqueline Peebles","doi":"10.1016/j.ajogmf.2025.101829","DOIUrl":"10.1016/j.ajogmf.2025.101829","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;The postpartum period represents the highest risk time for maternal morbidity and mortality. Patient navigation is a promising intervention to improve maternal outcomes during this high-risk period.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To compare care utilization and clinical outcomes pre- and post-implementation of a postpartum navigation program in a retrospective, matched cohort analysis.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;Pregnant patients &gt;32 weeks’ gestation at risk for postpartum morbidity were invited to participate in a postpartum navigation program between October 2023 and September 2024. Qualifying criteria included intrapartum complications, hypertensive disorders of pregnancy, diabetes, and/or risk factors for perinatal mood and anxiety disorders. The navigator conducted regular check-ins with enrolled patients at delivery, 2, 6, and 12 weeks postpartum to assess physical recovery and psychological health. A matched cohort was created with similarly high-risk patients who delivered in the 18 months before program implementation and received standard care. Subjects were matched 1:1 according to race, ethnicity, parity, delivery method, and high-risk criteria. We compared adherence to standard postpartum care recommendations and clinical outcomes between the matched groups. Program feasibility and acceptability were assessed using retention and patient satisfaction as endpoints.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Of the 365 patients who met the eligibility criteria, 167 agreed to participate. Five patients withdrew from the program prior to starting any program activities, and one did not have outcome data available. The 161 patients who remained enrolled were matched to historical controls, totaling a final sample size of 322 patients. All demographic and clinical characteristics were similar between the two groups except for gestational age at delivery, which was earlier in the control group (38.7 weeks, IQR 37.4–39.3) than the intervention group (39.0, IQR 37.7–39.6, &lt;em&gt;P=.&lt;/em&gt;047). Total attendance at a comprehensive postpartum visit within 12 weeks of birth did not differ (93.8% vs. 90.1%, &lt;em&gt;P=.&lt;/em&gt;22). After adjusting for gestational age at delivery, the intervention group was more likely to complete postpartum depression screening (AOR 1.65, 95% CI 1.02–2.67) and continue breastfeeding at 6 weeks postpartum (AOR 2.17, 95% CI 1.46–5.01). The intervention group had higher rates of enrollment in a remote hypertension monitoring program (98.5% vs. 89.1%, &lt;em&gt;P=.&lt;/em&gt;027), which recommends once-daily blood pressure (BP) monitoring for two weeks postpartum. Intervention participants also recorded a higher total number of BP measurements using the monitoring program (12 BPs [IQR 0–26] vs. 0 [IQR 0–2], &lt;em&gt;P&lt;.&lt;/em&gt;001). However, enrollment in remote monitoring did not remain statistically significant in the multivariate model. Regarding intervention retention, 80.7% of participants atte","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101829"},"PeriodicalIF":3.1,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe maternal morbidity and mortality across subtypes of hypertensive disorders in pregnancy 妊娠期高血压疾病亚型的严重孕产妇发病率和死亡率
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.ajogmf.2025.101831
Joyce H. Xu BA , Heather N. Czarny MD , Braxton Forde MD , Carri R. Warshak MD , Emily A. DeFranco DO, MS , Robert M. Rossi MD

Background

Hypertensive disorders in pregnancy (HDP) are increasingly common in the United States and encompass a spectrum of diagnoses, yet the distinct risk profiles of HDP subtypes remain poorly defined.

Objective

To assess the risk of severe maternal morbidity (SMM) and mortality among patients with HDP.

Study Design

This repeated cross-sectional study analyzed U.S. delivery hospitalizations using the 2015–2021 National Inpatient Sample. Patients were identified as having HDP and adverse outcomes using International Classification of Diseases, Tenth Revision (ICD-10) codes. HDP subtypes were classified as chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, superimposed preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, and eclampsia. The primary outcomes were SMM and mortality. Temporal trends in the diagnosis of HDP were analyzed using joinpoint regression to estimate the average annual percent change (AAPC). Adjusted multivariate logistic regression and population-attributable fractions (aPAF) were used to examine the association between HDP and SMM outcomes. Additional subgroup analysis were performed to estimate SMM risk by race and ethnicity.

Results

Among the 22,554,997 parturients in this study, 3,423,849 (15.2%) had HDP. From 2015 to 2021, the rate of HDP increased from 12.0% to 18.8% (AAPC +7.8%, 95% CI 7.6–8.0). Compared to those without, HDP was associated with a higher risk of SMM (0.5% vs 2.0%; adjusted odds ratio [aOR] 3.04, 95% CI 2.96–3.12) and maternal death (0.7 vs 2.5 per 10,000 delivery hospitalizations; aOR 2.41, 95% CI 1.97–2.95). Among SMM indicators, those with HDP were at highest risk for cardiovascular (aOR 5.14, 95% CI 4.81–5.49) and renal (aOR 8.30, 95% CI 7.82–8.80) SMM. Among HDP subtypes, HELLP syndrome and eclampsia were associated with high risk for all SMM subcategories (aOR 1.92–158.59). Overall, 26.6% (aPAF, 95% CI 25.9–27.3) of hospitalizations with SMM and 22.3% (aPAF, 95% CI 16.2–28.0) of hospitalizations with maternal death were attributable to HDP. Asian or Pacific Islander patients had the greatest SMM risk (aOR 3.47; 95% CI 3.15–3.83) among racial and ethnic groups. The aPAF between HDP and SMM (34.8%, 95% CI 33.2–36.4) was greater among non-Hispanic Black patients compared to other racial and ethnic groups.

Conclusion

HDP was significantly associated with an increased risk of SMM and mortality, with eclampsia and HELLP syndrome posing the highest risks.
背景:妊娠期高血压疾病(HDP)在美国越来越普遍,包括一系列诊断,但HDP亚型的独特风险特征仍不明确。目的:评价妊高征孕妇重度孕产妇发病(SMM)及死亡风险。研究设计:这项重复的横断面研究利用2015-2021年全国住院患者样本分析了美国分娩住院情况。使用国际分类诊断代码(第10版)确定患者为HDP和不良结局。HDP亚型分为慢性高血压、妊娠期高血压、无严重特征子痫前期、有严重特征子痫前期、叠加性子痫前期、HELLP(溶血、肝酶升高、低血小板)综合征和子痫。主要结局是SMM和死亡率。使用连接点回归分析HDP诊断的时间趋势,以估计平均年百分比变化(AAPC)。采用校正多元逻辑回归和人群归因分数(aPAF)来检验HDP和SMM结果之间的关系。另外进行亚组分析以估计按种族和民族划分的SMM风险。结果:在本研究的22,554,997例产妇中,3,423,849例(15.2%)患有HDP。从2015年到2021年,HDP率从12.0%上升到18.8% (AAPC +7.8%, 95% CI 7.6-8.0)。与没有妊娠的孕妇相比,HDP与更高的SMM风险相关(0.5% vs. 2.0%;调整优势比[aOR] 3.04, 95% CI 2.96-3.12)和孕产妇死亡(每10,000例住院分娩中0.7 vs 2.5; aOR 2.41, 95% CI 1.97-2.95)。在SMM指标中,HDP患者发生心血管(aOR 5.14, 95% CI 4.81-5.49)和肾脏(aOR 8.30, 95% CI 7.82-8.80) SMM的风险最高。在HDP亚型中,HELLP综合征和子痫与所有SMM亚型的高风险相关(aOR为1.92-158.59)。总体而言,因SMM住院的26.6% (aPAF, 95% CI 25.9-27.3)和因产妇死亡住院的22.3% (aPAF, 95% CI 16.2-28.0)可归因于HDP。亚洲或太平洋岛民患者在种族和族裔群体中SMM风险最高(aOR 3.47; 95% CI 3.15-3.83)。与其他种族和民族相比,非西班牙裔黑人患者中HDP和SMM之间的aPAF (34.8%, 95% CI 33.2-36.4)更高。结论:HDP与SMM和死亡风险增加显著相关,其中子痫和HELLP综合征的风险最高。
{"title":"Severe maternal morbidity and mortality across subtypes of hypertensive disorders in pregnancy","authors":"Joyce H. Xu BA ,&nbsp;Heather N. Czarny MD ,&nbsp;Braxton Forde MD ,&nbsp;Carri R. Warshak MD ,&nbsp;Emily A. DeFranco DO, MS ,&nbsp;Robert M. Rossi MD","doi":"10.1016/j.ajogmf.2025.101831","DOIUrl":"10.1016/j.ajogmf.2025.101831","url":null,"abstract":"<div><h3>Background</h3><div>Hypertensive disorders in pregnancy (HDP) are increasingly common in the United States and encompass a spectrum of diagnoses, yet the distinct risk profiles of HDP subtypes remain poorly defined.</div></div><div><h3>Objective</h3><div>To assess the risk of severe maternal morbidity (SMM) and mortality among patients with HDP.</div></div><div><h3>Study Design</h3><div>This repeated cross-sectional study analyzed U.S. delivery hospitalizations using the 2015–2021 National Inpatient Sample. Patients were identified as having HDP and adverse outcomes using International Classification of Diseases, Tenth Revision (ICD-10) codes. HDP subtypes were classified as chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, superimposed preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, and eclampsia. The primary outcomes were SMM and mortality. Temporal trends in the diagnosis of HDP were analyzed using joinpoint regression to estimate the average annual percent change (AAPC). Adjusted multivariate logistic regression and population-attributable fractions (aPAF) were used to examine the association between HDP and SMM outcomes. Additional subgroup analysis were performed to estimate SMM risk by race and ethnicity.</div></div><div><h3>Results</h3><div>Among the 22,554,997 parturients in this study, 3,423,849 (15.2%) had HDP. From 2015 to 2021, the rate of HDP increased from 12.0% to 18.8% (AAPC +7.8%, 95% CI 7.6–8.0). Compared to those without, HDP was associated with a higher risk of SMM (0.5% vs 2.0%; adjusted odds ratio [aOR] 3.04, 95% CI 2.96–3.12) and maternal death (0.7 vs 2.5 per 10,000 delivery hospitalizations; aOR 2.41, 95% CI 1.97–2.95). Among SMM indicators, those with HDP were at highest risk for cardiovascular (aOR 5.14, 95% CI 4.81–5.49) and renal (aOR 8.30, 95% CI 7.82–8.80) SMM. Among HDP subtypes, HELLP syndrome and eclampsia were associated with high risk for all SMM subcategories (aOR 1.92–158.59). Overall, 26.6% (aPAF, 95% CI 25.9–27.3) of hospitalizations with SMM and 22.3% (aPAF, 95% CI 16.2–28.0) of hospitalizations with maternal death were attributable to HDP. Asian or Pacific Islander patients had the greatest SMM risk (aOR 3.47; 95% CI 3.15–3.83) among racial and ethnic groups. The aPAF between HDP and SMM (34.8%, 95% CI 33.2–36.4) was greater among non-Hispanic Black patients compared to other racial and ethnic groups.</div></div><div><h3>Conclusion</h3><div>HDP was significantly associated with an increased risk of SMM and mortality, with eclampsia and HELLP syndrome posing the highest risks.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101831"},"PeriodicalIF":3.1,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expectant management versus selective fetal reduction in dichorionic-diamniotic twins following mid-trimester, preterm premature rupture of membranes in 1 twin: Review of literature and meta-analysis 双绒毛膜-双羊膜双胞胎妊娠中期、早产、胎膜早破一例的准产管理与选择性胎位减少:文献回顾和荟萃分析。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-05 DOI: 10.1016/j.ajogmf.2025.101824
Nissim Arbib MD , Anat Shmueli MD , Shiri Barbash-Hazan MD , Keren Tzadikevitch-Geffen MD , Hadas Miremberg MD , Shany Kolp-Asis MD , Kinneret Tenenbaum-Gavish MD , Yuval Gielchinsky MD , Eran Hadar MD

Objective

To compare maternal and neonatal outcomes following selective fetal reduction versus expectant management in dichorionic-diamniotic twin pregnancies complicated by mid-trimester preterm premature rupture of membranes in 1 sac.

Data sources

A systematic literature search of PubMed, Embase, and Scopus was conducted through March 2025.

Study eligibility criteria

Included studies were observational (case series or cohort studies) comparing selective fetal reduction versus expectant management in twin pregnancies with mid-trimester preterm premature rupture of membranes (prior to 24+0 weeks). Only studies reporting relevant maternal or neonatal outcomes were included.

Study appraisal and synthesis methods

Studies were assessed using the Newcastle-Ottawa Scale. Meta-analyses were performed using random- or fixed-effects models based on heterogeneity. Outcomes included perinatal survival, neonatal survival, latency period, gestational age at delivery, delivery ≥32 weeks, and other maternal and neonatal complications.

Results

Five retrospective studies met eligibility criteria, and 4 were included in the meta-analysis. Neonatal survival was higher with selective fetal reduction (74% vs 69%), though not statistically significant (OR=1.72, 95% CI=0.96–4.25). Perinatal survival was significantly lower with selective fetal reduction (33% vs 69%), when the reduced fetuses were included (OR=0.40, 95% CI=0.19–0.8). Selective fetal reduction significantly increased odds of delivery ≥32 weeks (67.4% vs 11.3%; OR=15.34, 95% CI=3.86–61.03). Latency and mean gestational age at delivery trended higher in the reduction group but did not reach statistical significance. Maternal and neonatal complications - including chorioamnionitis, cesarean delivery and respiratory morbidity - were less frequent following selective reduction, except for pulmonary hypoplasia, which was higher.

Conclusions

Selective fetal reduction after mid-trimester rupture in 1 sac of dichorionic-diamniotic twins increases the likelihood of delivery ≥32 weeks. Although most other outcome differences were not significant, these findings suggest that fetal reduction may be an alternative to expectant management when termination of the entire pregnancy is not optional.
目的:比较双绒毛膜-双羊膜双胎妊娠合并中期胎膜早破的产妇和新生儿结局。数据来源:截至2025年3月,对PubMed、Embase和Scopus进行了系统的文献检索。研究资格标准:纳入的研究是观察性的(病例系列或队列研究),比较选择性胎位减少与准产管理在双胎妊娠中期胎膜早破(24+0周之前)。仅纳入报告相关孕产妇或新生儿结局的研究。研究评价和综合方法:使用纽卡斯尔-渥太华量表对研究进行评估。采用基于异质性的随机或固定效应模型进行meta分析。结局包括围产期生存、新生儿生存、潜伏期、分娩胎龄、分娩≥32周以及其他孕产妇和新生儿并发症。结果:5项回顾性研究符合入选标准,4项纳入meta分析。选择性胎位减少的新生儿存活率更高(74%对69%),但没有统计学意义(OR=1.72, 95% CI=0.96-4.25)。当包括减少的胎儿时,选择性减少胎儿的围产期生存率显著降低(33%对69%)(OR=0.40, 95% CI=0.19-0.8)。选择性胎位减少显著增加≥32周分娩的几率(67.4% vs. 11.3%; OR=15.34, 95% CI=3.86-61.03)。减少组的分娩潜伏期和平均胎龄增高,但未达到统计学意义。产妇和新生儿并发症——包括绒毛膜羊膜炎、剖宫产和呼吸系统疾病——在选择性减量后发生率较低,但肺发育不全发生率较高。结论:双绒毛膜-双羊膜双胞胎妊娠中期单囊破裂后选择性胎位减少可增加≥32周分娩的可能性。虽然大多数其他结果差异不显著,但这些发现表明,当不能选择终止整个妊娠时,胎儿减少可能是一种替代妊娠管理的方法。
{"title":"Expectant management versus selective fetal reduction in dichorionic-diamniotic twins following mid-trimester, preterm premature rupture of membranes in 1 twin: Review of literature and meta-analysis","authors":"Nissim Arbib MD ,&nbsp;Anat Shmueli MD ,&nbsp;Shiri Barbash-Hazan MD ,&nbsp;Keren Tzadikevitch-Geffen MD ,&nbsp;Hadas Miremberg MD ,&nbsp;Shany Kolp-Asis MD ,&nbsp;Kinneret Tenenbaum-Gavish MD ,&nbsp;Yuval Gielchinsky MD ,&nbsp;Eran Hadar MD","doi":"10.1016/j.ajogmf.2025.101824","DOIUrl":"10.1016/j.ajogmf.2025.101824","url":null,"abstract":"<div><h3>Objective</h3><div>To compare maternal and neonatal outcomes following selective fetal reduction versus expectant management in dichorionic-diamniotic twin pregnancies complicated by mid-trimester preterm premature rupture of membranes in 1 sac.</div></div><div><h3>Data sources</h3><div>A systematic literature search of PubMed, Embase, and Scopus was conducted through March 2025.</div></div><div><h3>Study eligibility criteria</h3><div>Included studies were observational (case series or cohort studies) comparing selective fetal reduction versus expectant management in twin pregnancies with mid-trimester preterm premature rupture of membranes (prior to 24+0 weeks). Only studies reporting relevant maternal or neonatal outcomes were included.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>Studies were assessed using the Newcastle-Ottawa Scale. Meta-analyses were performed using random- or fixed-effects models based on heterogeneity. Outcomes included perinatal survival, neonatal survival, latency period, gestational age at delivery, delivery ≥32 weeks, and other maternal and neonatal complications.</div></div><div><h3>Results</h3><div>Five retrospective studies met eligibility criteria, and 4 were included in the meta-analysis. Neonatal survival was higher with selective fetal reduction (74% vs 69%), though not statistically significant (OR=1.72, 95% CI=0.96–4.25). Perinatal survival was significantly lower with selective fetal reduction (33% vs 69%), when the reduced fetuses were included (OR=0.40, 95% CI=0.19–0.8). Selective fetal reduction significantly increased odds of delivery ≥32 weeks (67.4% vs 11.3%; OR=15.34, 95% CI=3.86–61.03). Latency and mean gestational age at delivery trended higher in the reduction group but did not reach statistical significance. Maternal and neonatal complications - including chorioamnionitis, cesarean delivery and respiratory morbidity - were less frequent following selective reduction, except for pulmonary hypoplasia, which was higher.</div></div><div><h3>Conclusions</h3><div>Selective fetal reduction after mid-trimester rupture in 1 sac of dichorionic-diamniotic twins increases the likelihood of delivery ≥32 weeks. Although most other outcome differences were not significant, these findings suggest that fetal reduction may be an alternative to expectant management when termination of the entire pregnancy is not optional.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101824"},"PeriodicalIF":3.1,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pushing the limit: antenatal corticosteroids at 22 weeks’ gestation 突破极限:妊娠22周的产前皮质类固醇。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-11-04 DOI: 10.1016/j.ajogmf.2025.101812
Moti Gulersen MD, MSc
{"title":"Pushing the limit: antenatal corticosteroids at 22 weeks’ gestation","authors":"Moti Gulersen MD, MSc","doi":"10.1016/j.ajogmf.2025.101812","DOIUrl":"10.1016/j.ajogmf.2025.101812","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 12","pages":"Article 101812"},"PeriodicalIF":3.1,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Obstetrics & Gynecology Mfm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1